Figure 1.

Treatments with EGF and/or hGly²GLP-2 increase small intestinal weight in C57Bl/6 mice. (A) Male (n = 4–5) and female (n = 4–5) 6–8 wk C57Bl/6 mice were treated for 11 days with various combinations of vehicle, EGF, and/or hGly²GLP-2. (B) Body weight, (C) Small intestinal weight, (D) Small intestinal length, (E) Small intestinal weight/body weight and (F) Small intestinal weight/small intestinal length. All data were normalized by sex prior to combination within each treatment group to make n = 8–9. *P < 0.05, **P < 0.01, ***P < 0.001 as indicated; ##P < 0.01 vs hGly²GLP-2 alone.